News

Under this agreement, Cantel Medical, through its Saf-T-Pak and Crosstex business units, will manufacture National Safety Council (NSC) or Saf-T-Pak co-branded Flu Defense Kits and other product configurations

This was the first patient in a Phase I/II clinical trial study that is designed to assess the safety and feasibility of BL-1040 in up to 30 patients

WellPoint’s affiliated Health Plans’s decision to cover Treanda followed the FDA’s decision to grant it orphan drug status for chronic lymphocytic leukemia. WellPoint has a clinical guideline in

The emergency use authorization (EUA) mechanism was created by Congress to enable the FDA Commissioner to authorize the use of a drug that has not been approved, or

The project will explore the genetic basis of longevity and create a genetic, genealogic and medical database of the Parsi-Zoroastrian population. The Avestagenome Project takes a systems biology

The trial is studying the use of Medidur FA for the treatment of diabetic macular edema (DME). Fame is two, duplicate, double-masked, randomized, multi-center studies that are following

The completed study of 460 patients is one of two parallel Phase III clinical trials being conducted at 36 academic medical centers in the UK, Sweden, the Netherlands,

This patent was originally scheduled to expire on March 27, 2007. The interim extension was granted pursuant to a portion of the Hatch-Waxman Act that provides a process

Under the terms of the agreement, which is subject to Indian government approval, Medistem Laboratories will receive cash and equity in TriCell. TriCell will receive access to Medistem’s